Drug prices not justified by industry’s research and development spending

Most industry spending is not on research and development Government action needed to encourage research and development focused on public health priorities  High drug prices are not justified by industry’s spending on research and development (R&D), argue experts in The BMJ today.  Aris Angelis and colleagues point out that from ...

2024-06-04T10:24:37+00:0016 February 2023|Press release, The BMJ|

Scrapping England’s cancer plan is “a catastrophic decision that will cost lives” warn experts

The UK government’s proposal to roll England’s long term plan for cancer into one strategy covering all major conditions, such as cardiovascular disease, chronic respiratory disease, dementia, mental health conditions, and musculoskeletal disorders is “a catastrophic decision that will cost lives,” warn experts in The BMJ today. Professor Richard Sullivan ...

2024-06-04T10:23:43+00:0016 February 2023|Press release, The BMJ|

Most health claims on infant formula products seem to have little evidence

Most health claims on infant formula products seem to have little or no supporting evidence Stricter marketing regulations are urgently needed, urge researchers Most health and nutrition claims on infant formula products seem to be backed by little or no high quality scientific evidence, finds an international survey published by ...

2024-06-04T10:23:10+00:0016 February 2023|Press release, The BMJ|

The NHS paid private hospitals £2bn in the pandemic but some treated more private patients than NHS ones

New data shows some private hospitals treated few inpatients Experts are questioning why NHS England bought up private hospital’s entire capacity rather than paying for activity that was delivered Private hospitals were paid around £2bn to help the NHS during the first year of the covid pandemic. But an investigation ...

2024-06-04T10:25:13+00:0016 February 2023|Press release, The BMJ|

Covid vaccination in pregnancy protects infants against infection and hospital admission

Findings suggest that vaccination during pregnancy may have benefits for both mother and baby Two doses of mRNA covid-19 vaccine during pregnancy are highly effective against delta and moderately effective against omicron infection, and are linked to a lower risk of hospital admission in infants under six months of age, ...

2024-06-04T10:23:16+00:009 February 2023|Press release, The BMJ|
Go to Top